CeeNU

Active Ingredient(s): Lomustine, CCNU
FDA Approved: * August 4, 1976
Pharm Company: * BRISTOL MYERS SQUIBB
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



CeeNU Overview

Lomustine (INN), abbreviated as CCNU (original brand name (formerly available) is CeeNU, now marketed as Gleostine), is an alkylating nitrosourea compound used in chemotherapy. It is closely related to semustine and is in the same family as streptozotocin. It is a highly lipid-soluble drug,[2] thus it crosses the blood-brain barrier. This property makes it ideal for treating brain tumors, which is its primary use, although it is also used to treat Hodgkin lymphoma as a second-...

Read more CeeNU Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Lomustine

Recent CeeNU Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Lomustine, CCNU
  • Capsule: 100mg, 10mg, 10mg + 40mg + 100mg, 40mg, 5mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for CeeNU: (3 results)

Sorted by National Drug Code
  • 0015-3030 Ceenu 10 mg Oral Capsule by E.r. Squibb & Sons, L.L.C.
  • 0015-3031 Ceenu 40 mg Oral Capsule by E.r. Squibb & Sons, L.L.C.
  • 0015-3032 Ceenu 100 mg Oral Capsule by E.r. Squibb & Sons, L.L.C.

Other drugs which contain Lomustine, CCNU or a similar ingredient: (1 result)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 15 December 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA